Time to Recovery from COVID-19 and Its Predictors in Patients Hospitalized at Tibebe Ghion Specialized Hospital Care and Treatment Center, A Retrospective Follow-Up Study, North West Ethiopia

Table 1

Background clinical characteristics (presenting symptoms, comorbidities, and baseline laboratory values) of COVID-19 patients admitted to TGSH, North West Ethiopia, 2022 (n = 452).

Variables	Category	Outcome
		Censored	Event	Total
Fever	No	44 (12.6)	305 (87.4)	349 (100)
	Yes	11 (10.7)	92 (89.3)	103 (100)
Cough	No	15 (13.4)	97 (86.6)	112 (100)
	Yes	40 (11.8)	300 (88.2)	340 (100)
SOB	No	25 (10.6)	221 (89.4)	246 (100)
	Yes	30 (14.6)	176 (85.4)	206 (100)
Headache	No	49 (12.8)	334 (87.2)	383 (100)
	Yes	6 (8.7)	63 (91.3)	69 (100)
Chest pain	No	53 (12.8)	362 (87.2)	415 (100)
	Yes	2 (5.4)	35 (94.6)	37 (100)
Myalgia/arthralgia	No	47 (11.80	352 (88.2)	399 (100)
	Yes	8 (15.1)	45 (84.9)	53 (100)
Fatigue	No	50 (12.9)	337 (87.1)	387 (100)
	Yes	5 (7.7)	60 (92.3)	65 (100)
COVID-19 severity score	Mild	8 (9.2)	79 (90.8)	87 (100)
	Moderate	8 (5.3)	142 (94.7)	150 (100)
	Sever	39 (18.1)	176 (81.7)	215 (100)
Comorbidity	No	30 (10.0)	269 (90.0)	299 (100)
	Yes	25 (16.3)	128 (83.7)	153 (100)
WBC	Normal	36 (12)	265 (88.0)	301 (100)
	Low	2 (5.4)	35 (94.6)	37 (100)
	High	17 (14.9)	97 (85.1)	114 (100)
RBC	Normal	39 (11.2)	308 (88.8)	347 (100)
	Low	7 (18.4)	31 (81.6)	38 (100)
	High	9 (13.4)	58 (86.6)	67 (100)
Platelet	Normal	37 (11.3)	291 (88.7)	328 (100)
	Low	18 (15.7)	97 (84.3)	115 (100)
	High	1 (11.1)	8 (88.9)	9 (100)
Hgb	Normal	42 (12.3)	299 (87.7)	341 (100)
	Low	11 (11.7)	83 (88.3)	94 (100)
	High	2 (11.8)	15 (88.2)	17 (100)
Creatinine	Normal	14 (6.8)	192 (93.2)	206 (100)
	Low	6 (13.0)	40 (87.0)	46 (100)
	High	35 (17.5)	165 (82.5)	200 (100)